Clinical Trial: A Study to Evaluate the Safety and Efficacy of Multiple Dose of STSP-0902 in Patients With Oligozoospermia and/or Asthenozoospermia.

U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07833943) titled 'A Study to Evaluate the Safety and Efficacy of Multiple Dose of STSP-0902 in Patients With Oligozoospermia and/or Asthenozoospermia.' on Sept. 13.

Brief Summary: This is a Phase 2, randomized, double-blind, placebo-controlled, multiple dose study to evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of STSP-0902 in Patients with Oligozoospermia and/or Asthenozoospermia.

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Oligozoospermia and/or Asthenozoospermia

Intervention: DRUG: STSP-0902 injection

Subjects will receive the administration once weekly for sevral consecutive weeks

DRUG: Plac...